Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder

Next Previous
Search
Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Buprenorphine (Primary) ; Buprenorphine/naloxone (Primary)
  • Indications Opioid-related disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Indivior

    • Most Recent Events

    • 01 May 2022 Results investigating diverse array of outcomes for individuals with OUD at an average of 4.2 years post clinical trial participation from NCT023579011; NCT025100142; NCT02896296 & NCT03604861 were published in the Drug and Alcohol Dependence.
    • 08 Dec 2021 Subgroup analysis results presented in an Indivior media release.
    • 08 Dec 2021 According to an Indivior media release, subgroup analysis from this study will be presented at the 2021 Joint International Congress with ALBATROS and the 2021 World Association on Dual Disorder (WADD) .

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top